Advertisement

Topics

Recombinant Capital Company Profile

14:10 EST 9th December 2018 | BioPortfolio

Recombinant Capital (Recap) is a San Francisco Bay Area-based consulting firm specializing in biotechnology alliances, earned alliance revenues, product sales, employment agreements, company information and capitalization. Recap was founded in 1988 by Mark Edwards. Prior to founding Recap, Mr. Edwards was manager of business development at Chiron. Mr. Edwards has a bachelor's degree in economics and an MBA, both from Stanford University.

Location

2033 N Main Street, Suite 1050
Walnut Creek
California
94596-3722
United States of America

Contact

Phone: (925) 952-3870
Fax: (925) 952-3871
Email: info@recap.com


News Articles [496 Associated News Articles listed on BioPortfolio]

Editas Medicine Announces the Completion of the Recombinant DNA Advisory Committee (RAC) Registration Process

CAMBRIDGE, Mass., Aug. 16, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ: EDIT), a leading genome editing company, announced today the National Institutes of Health (NIH) Recombinant DNA A...

Brii Biosciences launches with $260mm

Brii Biosciences has launched with committed funding of $260mm from Arch Venture Partners, 6 Dimensions Capital, Boyu Capital, Yunfeng Capital, Sequoia Capital, and Blue Pool Capital.

Capital Bancorp, Inc. Announces Full Exercise and Closing of Underwriters' Option To Purchase ...

ROCKVILLE, Md., Oct. 4, 2018 /PRNewswire/ -- Capital Bancorp, Inc. ("Capital" or the "Company"), the bank holding company for Capital Bank, National Association, today announced Read more...

Capital Bancorp, Inc. Announces Closing of Initial Public Offering of Common Stock

ROCKVILLE, Md., Sept. 28, 2018 /PRNewswire/ -- Capital Bancorp, Inc. ("Capital" or the "Company"), the bank holding company for Capital Bank, National Association, today announced Read more...

How upstart VC firm Health Velocity Capital is looking differentiate themselves in a crowded field

Venture capital firm Health Velocity Capital, which is led by a trio of veteran investors, has closed its initial oversubscribed fund with $185 million in committed capital.

Milestone Pharmaceuticals closes $80mm Series D round

Cardiovascular-focused Milestone Pharmaceuticals Inc. raised $80mm in what looks to be its Series D financing led by RTW Investments, which was joined by other new backers Venrock Healthcare Capital P...

Bain Capital, Pfizer create new CNS company Cerevel Therapeutics

Cerevel Therapeutics has secured $350m funding from funds affiliated with Bain Capital Private Equity and Bain Capital Life Sciences. They have also committed to provide further capital if The post B...

Golub Capital BDC, Inc. Closes New $300 Million Credit Facility

NEW YORK, July 23, 2018 /PRNewswire/ -- Golub Capital BDC, Inc. (NASDAQ: GBDC), ("Golub Capital BDC" or the "Company"), a business development company, today announced Read more...

PubMed Articles [116 Associated PubMed Articles listed on BioPortfolio]

Association Between Community Social Capital and Hospital Readmission Rates.

Hospital readmissions remain frequent, and are partly attributable to patients' social needs. The authors sought to examine whether local community levels of social capital are associated with hospita...

Social Capital, Community Capacity, and Health.

The capacity to practice health behavior is different for each individual. Community capacity and social capital deal with understanding the relationship between community members and with the factors...

Is community social capital associated with subjective symptoms of dementia among older people? A cross-sectional study in Japan.

Many studies have reported the preventive effects of community social capital on health outcomes, such as mortality and incidence of diseases. However, evidence on the association between community so...

Social capital interventions in public health: A systematic review.

Despite two decades of research on social capital and health, intervention studies remain scarce. We performed a systematic review on social capital interventions in public health and searched the Pub...

A comparative study of social capital and hospital readmission in older adults.

Numerous factors contribute to hospital readmissions of older adults. The role social capital may play in preventing hospital readmissions is unknown. The aim of this descriptive, cross-sectional stud...

Clinical Trials [54 Associated Clinical Trials listed on BioPortfolio]

Social Capital and Engagement in Care Among Young Black Men Who Have Sex With Men Living With HIV

The study is a randomized controlled trial to evaluate the social capital intervention versus a general health promotion intervention (Health for Life; H4L) among groups of Young black men...

Slipped Capital Femoral Epiphysis Treatment

Slipped capital femoral epiphysis represents approximately 10.8 cases per 100,000 children. The primary source for the blood supply of the head of the femur is the deep branch of the media...

The Montreal Neighbourhood Networks and Healthy Aging Panel

Social networks, social capital, i.e., network-accessed resources, and neighbourhood environments have been shown associated with a range of health behaviours and conditions, including obe...

"Gait and Balance in Patients With SCFE"

Slipped Capital Femoral Epiphysis (SCFE) treated with one screw in situ fixation results in an altered gait. It is thought that the protraction of the pelvis at the affected side, seen in ...

Social Inequalities in Emergency Call and Emergency Response Patterns

Background: Inequality in access to healthcare is a challenge internationally. Despite that medical emergency calls can be considered as access point to pre-hospital emergency care and ...

Companies [1104 Associated Companies listed on BioPortfolio]

Vaxart, Inc.

Vaxart is a privately owned company developing oral recombinant vaccines based on its proprietary delivery platform. The Vaxart platform is suitable to deliver any protein vaccine...

rEVO Biologics

rEVO Biologics is a rare disease company focused on developing and delivering first and next-generation therapeutics that are more cost effective to produce than traditional recom...

Irving Place Capital

Irving Place Capital invests private equity capital in buyouts, recapitalizations, and growth capital opportunities alongside superior management teams. Irving Place Capital focus...

MCG Capital Corporation

MCG Capital Corporation is a solutions-focused commercial finance company providing capital and advisory services to middle-market companies throughout the United States. Our inve...

Praesidian Capital

Praesidian Capital partners with small and mid-sized businesses, providing private debt capital. With a focus on its core competency in mezzanine financing, Praesidian Capital invests in established, ...

More Information about "Recombinant Capital" on BioPortfolio

We have published hundreds of Recombinant Capital news stories on BioPortfolio along with dozens of Recombinant Capital Clinical Trials and PubMed Articles about Recombinant Capital for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Recombinant Capital Companies in our database. You can also find out about relevant Recombinant Capital Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...


Corporate Database Quicklinks



Searches Linking to this Company Record